Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBaylor Research Institute
About this trial
A major goal of this protocol is to support biomarker studies in advanced lung diseases, lung transplantation care, and to improve our understanding of the effects of viral and other infectious exposures to outcomes in our lung transplant and ALD patient populations.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All individuals aged 18 years and older
Persons who have undergone lung transplantation at Baylor University Medical Center in the previous 10 years
Individual is able to understand and sign the informed consent form
Disqualifiers
Significant documented anemia (hemoglobin <8 g/dL)
Blood transfusions within past 3 weeks
Active cancer (non-skin cancers)
Enrollment against doctor recommendation
Trial population
Lung transplant recipients
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Patient Biospecimen Registry (observational and blood sampling)
Other interventionClinical data collected at every blood sample collection visit.
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: Lung transplant Recipients1 intervention
Trial outcomes
Primary outcomes
1
Diagnosis of patients with lung transplant
ICD 10 code for underlying lung disease
Time frame
5 yearsSecondary outcomes
1
Survival
Date of death
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov